3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Pancreatic Ductal
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
budigalimab
1
Long Interspersed Nucleotide Elements
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anophthalmia with pulmonary hypoplasia
×
Long Interspersed Nucleotide Elements
×
1 year
×
Clear all
NCT05475366
2026-05-01
PACsign
Institut Curie
Phase NA
Recruiting
85 enrolled